A critical role for NF2 and the Hippo pathway in branching morphogenesis

Nature Communications

Volumn 7, Issue , 2016, Pages

  Reginensi, Antoine ^a   Enderle, Leonie ^a   Gregorieff, Alex ^a   Johnson, Randy L ^b   Wrana, Jeffrey L ^a,c   McNeill, Helen ^a,c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CASPASE 3; DUAL SPECIFICITY PHOSPHATASE 6; LAMININ; LATS1 PROTEIN; LATS2 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; NEUROFIBROMATOSIS TYPE 2 PROTEIN; NEUROFIBROMIN; NUCLEAR PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN RET; PROTEIN ZO1; SPROUTY 1 PROTEIN; SPROUTY PROTEIN; TRANSCRIPTION FACTOR PAX2; UNCLASSIFIED DRUG; UVOMORULIN; WNT11 PROTEIN; YAP PROTEIN; HIPPO PROTEIN, MOUSE; LATS1 PROTEIN, MOUSE; LATS2 PROTEIN, MOUSE; MERLIN; PHOSPHOPROTEIN; PROTEIN SERINE THREONINE KINASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; YAP PROTEIN, MOUSE;

BIOCHEMISTRY; CELLS AND CELL COMPONENTS; GENE EXPRESSION; MORPHOGENESIS; PHYSIOLOGICAL RESPONSE; RODENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRANCHING MORPHOGENESIS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; FEMALE; GENE OVEREXPRESSION; HAPLOINSUFFICIENCY; KIDNEY AGENESIS; KIDNEY DEVELOPMENT; KIDNEY HYPOPLASIA; MALE; MOSAICISM; MOUSE; NEWBORN; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; URETER; URETERIC BUD; ANIMAL; EMBRYOLOGY; GENETICS; KIDNEY; KNOCKOUT MOUSE; METABOLISM; MORPHOGENESIS; TRANSGENIC MOUSE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; KIDNEY; MICE, KNOCKOUT; MICE, TRANSGENIC; MORPHOGENESIS; NEUROFIBROMIN 2; PHOSPHOPROTEINS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; URETER;

EID: 84982709265     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms12309     Document Type: Article

References (30)

1. Costantini, F. & Kopan, R. Patterning a complex organ: branching morphogenesis and nephron segmentation in kidney development. Dev. Cell 18, 698-712 (2010).
2. Short, K. M. et al. Global quantification of tissue dynamics in the developing mouse kidney. Dev. Cell 29, 188-202 (2014).
3. Costantini, F. Genetic controls and cellular behaviors in branching morphogenesis of the renal collecting system. Wiley Interdiscip. Rev. Dev. Biol. 1, 693-713 (2012).
4. Shakya, R., Watanabe, T. & Costantini, F. The role of GDNF/Ret signaling in ureteric bud cell fate and branching morphogenesis. Dev. Cell 8, 65-74 (2005).
5. Moore, M. W. et al. Renal and neuronal abnormalities in mice lacking GDNF. Nature 382, 76-79 (1996).
6. Schuchardt, A., D'Agati, V., Larsson-Blomberg, L., Costantini, F. & Pachnis, V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367, 380-383 (1994).
7. Cacalano, G. et al. GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron 21, 53-62 (1998).
8. Cooper, J. & Giancotti, F. G. Molecular insights into NF2/Merlin tumor suppressor function. FEBS Lett. 588, 2743-2752 (2014).
9. Lin, A. L. & Gutmann, D. H. Advances in the treatment of neurofibromatosisassociated tumours. Nat. Rev. Clin. Oncol. 10, 616-624 (2013).
10. Schroeder, R. D., Angelo, L. S. & Kurzrock, R. NF2/merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations. Oncotarget 5, 67-77 (2014).
11. Staley, B. K. & Irvine, K. D. Hippo signaling in Drosophila: recent advances and insights. Dev. Dyn. 241, 3-15 (2012).
12. Zhao, B., Lei, Q. Y. & Guan, K. L. The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr. Opin. Cell Biol. 20, 638-646 (2008).
13. Halder, G. & Johnson, R. L. Hippo signaling: growth control and beyond. Development 138, 9-22 (2011).
14. Pan, D. The hippo signaling pathway in development and cancer. Dev. Cell 19, 491-505 (2010).
15. Harvey, K. & Tapon, N. The Salvador-Warts-Hippo pathway-an emerging tumour-suppressor network. Nat. Rev. Cancer 7, 182-191 (2007).
16. Yin, F. et al. Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell 154, 1342-1355 (2013).
17. Yu, F. X., Zhao, B. & Guan, K. L. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell 163, 811-828 (2015).
18. Dupont, S. et al. Role of YAP/TAZ in mechanotransduction. Nature 474, 179-183 (2011).
19. Zhao, H. et al. Role of fibroblast growth factor receptors 1 and 2 in the ureteric bud. Dev. Biol. 276, 403-415 (2004).
20. Lu, B. C. et al. Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis. Nat. Genet. 41, 1295-1302 (2009).
21. Ihermann-Hella, A. et al. Mitogen-activated protein kinase (MAPK) pathway regulates branching by remodeling epithelial cell adhesion. PLoS Genet. 10, e1004193 (2014).
22. Gladden, A. B., Hebert, A. M., Schneeberger, E. E. & McClatchey, A. I. The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex. Dev. Cell 19, 727-739 (2010).
23. Lavado, A. et al. Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators. Development 140, 3323-3334 (2013).
24. Kuure, S., Chi, X., Lu, B. & Costantini, F. The transcription factors Etv4 and Etv5 mediate formation of the ureteric bud tip domain during kidney development. Development 137, 1975-1979 (2010).
25. Packard, A. et al. Luminal mitosis drives epithelial cell dispersal within the branching ureteric bud. Dev. Cell 27, 319-330 (2013).
26. Reginensi, A. et al. Yap and Taz are required for Ret-dependent urinary tract morphogenesis. Development 142, 2696-2703 (2015).
27. Reginensi, A. et al. Yap-and Cdc42-dependent nephrogenesis and morphogenesis during mouse kidney development. PLoS Genet. 9, e1003380 (2013).
28. Heallen, T. et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 332, 458-461 (2011).
29. Giovannini, M. et al. Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev. 14, 1617-1630 (2000).
30. Gregorieff, A., Liu, Y., Inanlou, M. R., Khomchuk, Y. & Wrana, J. L. Yapdependent reprogramming of Lgr5() stem cells drives intestinal regeneration and cancer. Nature 526, 715-718 (2015).